Team Successfully Deploys MHS GENESIS to 18
additional Military Commands in latest Wave
RESTON,
Va., Oct. 10, 2022 /PRNewswire/ -- The Leidos
Partnership for Defense Health (LPDH) today announced it
successfully delivered the MHS GENESIS electronic health record to
an additional 10,000 clinicians and providers as part of its latest
double Wave deployment (Waves JACKSONVILLE/EGLIN), spanning 18 new Military
Treatment Facility Commands in Alabama, Florida, Georgia, Tennessee, Mississippi and South Carolina. The latest revenue cycle
capability integrates new patient accounting, medical coding, and
patient registration/access capabilities into the existing MHS
GENESIS system.
"Revenue cycle is a fully-integrated platform that will replace
paper-based practices and introduce a new clinically-driven patient
accounting system, including medical coding software and a
comprehensive billing database for the military health system,"
said Liz Porter, Leidos Health Group
president. "This new capability will improve communication
between the clinical and business communities while providing
insights into overall care and readiness costs."
LPDH designed and developed MHS GENESIS, the Military Health
System's new electronic health record, and has been providing
program management and technical expertise to the Program Executive
Office Defense Healthcare Management Systems (PEO DHMS) since
2015.
The MHS GENESIS system is now operational at over 1,800
locations and reaches 5.1 million DOD beneficiaries — approximately
67% deployed.
"The revenue cycle capability includes Electronic Data
Interchange (EDI) support with an updated front-end patient
identification and registration process," noted Holly Joers, PEO DHMS. "The MHS GENESIS system
continues to leverage commercial best practices to help improve
clinical outcomes with each deployment. The program is on schedule
with eight additional deployments planned through the end of
2023."
MHS GENESIS is being deployed across the continental
United States and overseas through
a total of 23 waves. Each Wave will target a specific region over
one year, with an average of three hospitals and numerous physical
locations for each Wave. This approach enables the DOD to take full
advantage of lessons learned from prior Waves to maximize
subsequent Waves' efficiencies. DOD expects to complete full
deployment of MHS GENESIS to garrison facilities by the end of
calendar year 2023.
About Leidos
Leidos is a Fortune 500® technology, engineering, and science
solutions and services leader working to solve the world's toughest
challenges in the defense, intelligence, civil, and health markets.
The company's 44,000 employees support vital missions for
government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual
revenues of approximately $13.7
billion for the fiscal year ended December 31, 2021. For more information, visit
www.Leidos.com.
About LPDH
The Leidos Partnership consists of four core partners - Leidos,
Oracle Cerner Corporation, Accenture and Henry Schein One - along with approximately 35
supporting businesses. Together, they deliver an integrated,
modern, secure health information system that includes an
electronic health record system, a dental system, identity
management capability, Cybersecurity, and other supporting
components. MHS GENESIS will serve as the system of record,
providing a single, integrated solution for managing the health and
military readiness of the force for DOD and the Department of
Veterans Affairs.
Certain statements in this announcement constitute
"forward-looking statements" within the meaning of the rules and
regulations of the U.S. Securities and Exchange Commission
(SEC). These statements are based on management's current
beliefs and expectations and are subject to significant risks and
uncertainties. These statements are not guarantees of future
results or occurrences. A number of factors could cause our actual
results, performance, achievements, or industry results to be
different from the results, performance, or achievements expressed
or implied by such forward-looking statements. These factors
include, but are not limited to, the "Risk Factors" set forth in
Leidos' Annual Report on Form 10-K for the fiscal year ended
December 31, 2021, and other such
filings that Leidos makes with the SEC from time to time. Readers
are cautioned not to place undue reliance on such forward-looking
statements, which speak only as of the date hereof. Leidos does not
undertake to update forward-looking statements to reflect the
impact of circumstances or events that arise after the date the
forward-looking statements were made.
Contact:
Melissa Dueñas
(571)
526-6850
Melissa.L.Duenas@leidos.com
Thomas Doheny
(571) 474-4735
Dohenyt@leidos.com
Brandon VerVelde
(571) 526-6257
Brandon.p.vervelde@leidos.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/leidos-partnership-launches-new-revenue-cycle-capability-for-dod-ehr-301644174.html
SOURCE Leidos